Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchy

TUNG-HUNG SUSHIH-JER HSUJIA-HORNG KAO2022-09-292022-09-292022-020929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/623265enSORAFENIB; LENVATINIB[SDGs]SDG3Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchyshort survey10.1016/j.jfma.2021.08.018344547962-s2.0-85113418921WOS:000749987400002https://scholars.lib.ntu.edu.tw/handle/123456789/582756